Baird Medical Investment Holdings Ltd
BDMDNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for BDMD. That does not mean none is planned.
Get an email about BDMD's next catalysts
Track Baird Medical Investment Holdings (BDMD) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (regulatory event).See the timeline
1 upcoming, 0 past
Regulatory Decision - Microwave ablation (MWA) system
For Soft tissue ablation; solid tumors; benign thyroid nodules. Baird Medical received a Nasdaq notice dated November 2, 2026 for failing to meet the $1.00 minimum bid price requirement. The company has until May 3, 2027 to regain compliance, with shares continuing to trade uninterrupted.
SourceMarket Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Baird Medical Investment Holdings Ltd's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Baird Medical Investment Holdings Ltd (BDMD) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track BDMD biotech catalysts?→
Add BDMD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Baird Medical Investment Holdings Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.